Pain relief using implantable neurostimulation has come on a lot in recent times. For evidence, try searching our pages. Now … continue reading “Pain Relief Boost with Spinal Cord Stimulator Approval”
Pain management
Medtronic DTM™ Spinal Cord Stimulation Therapy Outperforms Conventional SCS Therapy for Back Pain Relief at 12 Months
Statistically significant 12-month results from a large, multicenter randomized controlled trial confirm 84% Back Pain Responder Rate and 69% Profound … continue reading “Medtronic DTM™ Spinal Cord Stimulation Therapy Outperforms Conventional SCS Therapy for Back Pain Relief at 12 Months”
Medtronic’s EvolveSM Workflow with Spinal Cord Stimulation Offers Hope for Back and Leg Pain Sufferers, Says Study
Prospective data demonstrates effective pain relief and improved function in patients with intractable back and leg pain
Non-Invasive Headache Therapy System Selected for NHS England Innovation and Technology Payment Program
electroCore’s gammaCore™ chosen by NHS England to be funded by the Innovation and Technology Payment Program to support adoption in the U.K.
First Patient in Study to Assess Pain Control and Oral Opioid Elimination with Targeted Drug Delivery
Study will assess SynchroMed™ II Intrathecal Drug Delivery System in patients who have weaned off oral opioids
Abbott Launches Proclaim™ DRG System for Sufferers of Complex Regional Pain Syndrome
Helping treat patients with debilitating chronic pain and provideingrelief from hard-to-treat neuropathic conditions
FDA Approval and U.S. Launch of Medtronic’s New Chronic Intractable Pain Platform
Intellis includes the world’s smallest implantable spinal cord stimulator
The Case for Spinal Cord Stimulation in Chronic Pain
Physician roundtable suggests SCS should be first port of call in view of opioid health crisis
FDA Approves St. Jude Medical BurstDR™ Spinal Cord Stimulation for Chronic Pain
BurstDR stimulation targets chronic pain patients with a new therapy option designed to provide less pain, less suffering and less therapy maintenance
U.S. FDA Approval for Boston Scientific’s Precision Montage™ MRI Spinal Cord Stimulator System
Full-Body MRI access expands Spinal Cord Stimulation offering and brings customized therapy to more patients suffering from chronic pain
Stimwave’s Miniature Peripheral Nerve Stimulator (PNS) Wireless Pain Relief Cleared for Sale
FDA Clears revolutionary tiny device that offers alternative to opioids for chronic pain sufferers
FDA Clears NeuroMetrix Next Generation Quell® Wearable Pain Relief Technology
New clearance for use of Quell Relief smartphone app provides unprecedented level of convenience and comfort when usi treat chronic pain
FDA Approves St. Jude’s New User-Friendly Chronic Pain System
Patient-centric, recharge-free, upgradeable, MR-conditional, the Proclaim™ Elite SCS System targets patients’ quality of life
Only MR-Conditional Rechargeable Spinal Cord Stimulator With Burst Stimulation Gets CE Mark
St. Jude has gained CE mark approval for its Prodigy MRI™ spinal cord stimulation therapy, the first of its kind to offer MRI compatibility and Burst stimulation
Axium™ Trumps Traditional Spinal Cord Stimulation for Chronic Lower Limb Pain Relief
New study data points to St. Jude’s Dorsal Root Ganglion stimulator delivering better pain relief than traditional spinal cord stimulation.
CE Mark for St. Jude’s “Industry First” Neuromodulation Trial System
St. Jude Medical, Inc., has gained CE Mark approval and announced the European launch of its Invisible Trial System, an app-based and wireless neuromodulation programming system leveraging Apple™ iPod touch™ and iPad mini™ technology.